Alkem licenses technology from Harvard to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
This advanced technology for Diabetic Foot Ulcer (DFU), management has a high scope of preventing amputations in diabetic patients. It has no definitive treatment in India. This technology will be available at affordable rates
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
Subscribe To Our Newsletter & Stay Updated